Uterine fibroids are a common medical condition that affects many women, particularly those of reproductive age. These non-cancerous growths can cause a range of symptoms, including heavy menstrual bleeding, pelvic pain, and infertility. While surgery has traditionally been the most common treatment option for uterine fibroids, uterine fibroid embolization (UFE) is an effective alternative that uses specialized embolization agents to block blood flow to the fibroids. Uterine fibroid embolization (UFE) is an effective, non-surgical method used to treat uterine fibroids in the fertile women population.
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞:
https://www.alliedmarketresearch.com/request-toc-and-sample/1508
UFE involves the injection of embolization agents into the blood vessels that supply the fibroids. These agents are tiny particles that block the blood flow to the fibroids, causing them to shrink and die off. Unlike surgery, UFE is a minimally invasive procedure that does not require general anesthesia or an incision.
There are several types of embolization agents that can be used for UFE, including polyvinyl alcohol (PVA) particles and trisacryl gelatin microspheres. These agents are designed to be biocompatible and safe for use in the body.
One of the advantages of UFE is that it is a same-day procedure, which means that patients can usually go home on the same day as the procedure. Recovery time is also shorter than with surgery, with most patients able to return to their normal activities within a week or two.
♦ 𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/purchase-enquiry/1508
UFE is an effective treatment option for many women with uterine fibroids. It has a success rate of around 85-90%, with most patients experiencing significant improvement in their symptoms. Additionally, UFE is a safe procedure, with a low risk of complications.
In conclusion, uterine fibroid embolization agents are an effective alternative to surgery for the treatment of uterine fibroids. This minimally invasive procedure offers many advantages over surgery, including a shorter recovery time and a lower risk of complications. If you are experiencing symptoms of uterine fibroids, speak to your doctor about the benefits of UFE.
Key Market Players –
Astellas Pharma, Nippon Kayaku, Pfizer, Boston Scientific Corporation, Merit Medical Systems, Inc., Cook Medical, CeloNova, Biosciences
By Region –
North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
♦ Procure Complete Report (220 Pages PDF with Insights, Charts, Tables, and Figures) @
https://www.alliedmarketresearch.com/uterine-fibroid-embolization-agents-market/purchase-options
About Us –
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com